Riverview Trust Company’s Bristol-Myers Squibb BMY Stock Holding History

Riverview Trust Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$72.3K	Hold	1,254	–	–	0.09%	99
2026 Q1	$76.1K	Sell	1,254 -217	-15%	-$12.7K	0.09%	97
2025 Q4	$79.3K	Hold	1,471	–	–	0.1%	98
2025 Q3	$66.3K	Sell	1,471 -1,867	-56%	-$87.2K	0.08%	115
2025 Q2	$155K	Sell	3,338 -497	-13%	-$24.4K	0.19%	71
2025 Q1	$234K	Sell	3,835 -48	-1%	-$2.8K	0.23%	76
2024 Q4	$220K	Buy	3,883 +511	+15%	+$28.6K	0.2%	83
2024 Q3	$174K	Sell	3,372 -1,264	-27%	-$59.3K	0.15%	107
2024 Q2	$193K	Buy	4,636 +1,388	+43%	+$62.1K	0.18%	87
2024 Q1	$176K	Sell	3,248 -1,081	-25%	-$55.1K	0.14%	109
2023 Q4	$222K	Hold	4,329	–	–	0.23%	91
2023 Q3	$251K	Sell	4,329 -244	-5%	-$15K	0.22%	76
2023 Q2	$292K	Sell	4,573 -794	-15%	-$53.2K	0.27%	62
2023 Q1	$372K	Hold	5,367	–	–	0.34%	51
2022 Q4	$386K	Sell	5,367 -657	-11%	-$49.5K	0.37%	51
2022 Q3	$428K	Buy	6,024 +887	+17%	+$64.3K	0.41%	49
2022 Q2	$396K	Hold	5,137	–	–	0.35%	55
2022 Q1	$375K	Buy	5,137 +1,525	+42%	+$102K	0.28%	62
2021 Q4	$225K	Buy	3,612 +1,577	+77%	+$92.5K	0.13%	79
2021 Q3	$120K	Buy	2,035 +1,471	+261%	+$96.9K	0.13%	109
2021 Q2	$38K	Hold	564	–	–	0.04%	167
2021 Q1	$36K	Hold	564	–	–	0.04%	163
2020 Q4	$35K	Hold	564	–	–	0.04%	165
2020 Q3	$34K	Hold	564	–	–	0.04%	164
2020 Q2	$33K	Sell	564 -63	-10%	-$3.77K	0.03%	172
2020 Q1	$35K	Hold	627	–	–	0.03%	162
2019 Q4	$40K	Hold	627	–	–	0.03%	180
2019 Q3	$32K	Hold	627	–	–	0.02%	193
2019 Q2	$28K	Hold	627	–	–	0.02%	200
2019 Q1	$30K	Hold	627	–	–	0.02%	197
2018 Q4	$33K	Buy	+627	New	+$33.7K	0.03%	173

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Riverview Trust Company's BMY Position: Q2 2026 in Review

Riverview Trust Company held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 1,254 shares worth $72.3K. The position accounts for 0.09% of the portfolio, ranked #99.

Riverview Trust Company first reported a position in BMY in Q4 2018 and has held it in 31 quarters since. The position peaked at $428K in Q3 2022. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Riverview Trust Company held 1,254 shares of Bristol-Myers Squibb worth $72.3K as of Q2 2026.
Riverview Trust Company left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.09% of Riverview Trust Company's portfolio in Q2 2026, its #99 holding.
Riverview Trust Company first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 31 quarters since.
Riverview Trust Company's Bristol-Myers Squibb position peaked at $428K in Q3 2022.
2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Riverview Trust Company's 13F filing for Q2 2026, filed 3 Aug 2026.